BioDiscovery was founded in 1997, in Los Angeles, California. They develop advanced software solutions for the analysis of data from high-throughput microarray and next-generation sequencing technologies. The company has a property portfolio encompassing six issued U.S. patents and a significant number of pending applications. BioDiscovery's software product consists of three umbrella offerings: Nexus Copy Number, NxClinical & Nexus Expression. The company's present headquarters are in El Segundo, California.